Why Alphatec Holdings (ATEC) Is Up 17.9% After Raising 2025 Guidance and Reporting Strong Q3

• Alphatec Holdings, Inc. recently raised its full-year 2025 revenue guidance to US$760 million and reported third quarter results that exceeded analyst expectations, highlighting a 30% year-over-year revenue increase and improvement in operating results.
• Surgeon adoption grew by 26% during the period, signaling expanding clinical traction and supporting future revenue potential for the company's spinal surgery platform.
• We'll explore how Alphatec's upgraded guidance and stronger surgeon adoption reshape the company’s investment narrative and future outlook.

Find companies with promising cash flow potential yet trading below their fair value.

Alphatec Holdings Investment Narrative Recap

To be a shareholder in Alphatec Holdings, you have to believe in the ongoing growth of the spinal surgery market and Alphatec’s ability to convert surgeon adoption into durable revenue gains, despite persistent net losses. The recent guidance upgrade reinforces confidence in short-term revenue momentum, with the main catalyst being surgeon adoption and the biggest risk remaining the pressure of ongoing operating losses. The uplift in guidance does not materially reduce risk if the company’s consistent cash burn persists alongside revenue growth.

Among recent announcements, Alphatec’s upgraded full-year revenue guidance to US$760 million stands out as directly relevant. This signals the company’s confidence in sustaining robust top-line expansion, anchored in successful surgeon adoption and broader market reach. For investors focused on near-term growth catalysts, this guidance lift highlights strong procedural momentum but does not resolve longer-term concerns around profitability and cash flow discipline.

However, if revenue growth slows or falls short, ongoing operating losses could amplify the financial risk investors should be aware of...

Read the full narrative on Alphatec Holdings (it's free!)

Alphatec Holdings' outlook anticipates $1.1 billion in revenue and $93.9 million in earnings by 2028. Achieving this would require annual revenue growth of 17.4% and an earnings increase of $259.9 million from the current earnings of -$166.0 million.

Uncover how Alphatec Holdings' forecasts yield a $20.54 fair value, a 8% upside to its current price.

Exploring Other Perspectives

Four fair value estimates from the Simply Wall St Community for Alphatec range from US$0.00 to US$59.91, revealing sharply divided outlooks. Consider the potential impact of persistent operating losses on future performance as you weigh these contrasting views.

Explore 4 other fair value estimates on Alphatec Holdings - why the stock might be worth less than half the current price!

Build Your Own Alphatec Holdings Narrative

Disagree with existing narratives? Create your own in under 3 minutes - extraordinary investment returns rarely come from following the herd.

• A great starting point for your Alphatec Holdings research is our analysis highlighting 2 key rewards and 2 important warning signs that could impact your investment decision.
• Our free Alphatec Holdings research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Alphatec Holdings' overall financial health at a glance.

Searching For A Fresh Perspective?

Early movers are already taking notice. See the stocks they're targeting before they've flown the coop:

• Uncover the next big thing with financially sound penny stocks that balance risk and reward.
• These 16 companies survived and thrived after COVID and have the right ingredients to survive Trump's tariffs. Discover why before your portfolio feels the trade war pinch.
• AI is about to change healthcare. These 33 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com